This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
What Downbeat 2018? These 5 Top Stocks Are Up More Than 100%
by Sanghamitra Saha
These five stocks gained more than 100% defying the market sluggishness this year.
Enova International (ENVA) Hits Fresh Highs: Is There Still Room to Run?
by Zacks Equity Research
Enova International, Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for ENVA for clues.
Top 5 Stocks With Impressive Net Profit Margin
by Zacks Equity Research
Net profit margin can turn out to be an accurate point of reference to gauge the potential of a company's operations and cost-control measures.
Navient's (NAVI) Ratings Affirmed by Moody's, Outlook Stable
by Zacks Equity Research
Affirmation of Navient's (NAVI) ratings indicates steady financial performance and good asset quality.
Enova International (ENVA) Hits Fresh Highs: Is There Still Room to Run?
by Zacks Equity Research
Enova International, Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for ENVA for clues.
4 Reasons You Should Invest in Ally Financial (ALLY) Stock
by Zacks Equity Research
Solid earnings and revenue growth prospects make Ally Financial (ALLY) a good investment option now.
Zacks.com highlights: BayCom, Enova International, QuinStreet, CommerceWest Bank N.A. and AMN Healthcare Services
by Zacks Equity Research
Zacks.com highlights: BayCom, Enova International, QuinStreet, CommerceWest Bank N.A. and AMN Healthcare Services
5 Stocks with Recent Price Strength to Boost Your Portfolio
by Zacks Equity Research
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Zacks.com highlights: Cinemark Holdings, Hasbro, Enova International, Array BioPharma and TechTarget
by Zacks Equity Research
Zacks.com highlights: Cinemark Holdings, Hasbro, Enova International, Array BioPharma and TechTarget
How to Uncover Institutional Buying
by Kevin Matras
Kevin Matras goes over how to screen for weekly volume increases to uncover institutional buying. Highlighted stocks include CNK, HAS, ENVA, ARRY and TTGT.
Market in Correction: These ETFs & Stocks Still Offer Value
by Sanghamitra Saha
These stocks and ETFs still have some value hidden amid the bloodbath in the market.
5 Stocks to Buy on the Dip
by David Bartosiak
If you liked these stocks yesterday, you'll love them today after the market has provided a great buying opportunity.
Is Enova International (ENVA) a Suitable Value Stock?
by Zacks Equity Research
Enova International (ENVA) appears to be a good choice for value investors right now, given its favorable P/E and P/S metrics.
Options Traders Expect Huge Moves in Enova International (ENVA) Stock
by Zacks Equity Research
Enova International (ENVA) needs Investors to pay close attention to the stock based on moves in the options market lately.
New Strong Sell Stocks for October 16th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Are Options Traders Betting on a Big Move in Enova International (ENVA) Stock?
by Zacks Equity Research
Investors in Enova International (ENVA) need to pay close attention to the stock based on moves in the options market lately.
Enova International (ENVA) Worth a Look: Stock Gains 5.2%
by Zacks Equity Research
Enova International, Inc. (ENVA) shares rose a little above 5% in the last trading session.
New Strong Sell Stocks for February 6th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: